In the last trading session, 1.36 million shares of the TELA Bio Inc (NASDAQ:TELA) were traded, and its beta was 0.89. Most recently the company’s share price was $1.24, and it changed around -$0.16 or -11.43% from the last close, which brings the market valuation of the company to $49.04M. TELA currently trades at a discount to its 52-week high of $6.50, offering almost -424.19% off that amount. The share price’s 52-week low was $1.28, which indicates that the current value has fallen by an impressive -3.23% since then. We note from TELA Bio Inc’s average daily trading volume that its 10-day average is 0.6 million shares, with the 3-month average coming to 205.84K.
TELA Bio Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.40. If we narrow it down even further, the data shows that 0 out of 6 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 1 recommended TELA as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. TELA Bio Inc is expected to report earnings per share of -0.21 for the current quarter.
TELA Bio Inc (NASDAQ:TELA) trade information
Instantly TELA has showed a red trend with a performance of -11.43% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 2.4781 on recent trading dayincreased the stock’s daily price by 49.96%. The company’s shares are currently down -58.94% year-to-date, but still down -47.23% over the last five days. On the other hand, TELA Bio Inc (NASDAQ:TELA) is -53.21% down in the 30-day period. We can see from the shorts that 0.47 million shares have been sold at a short interest cover period of 2.62 day(s).
The consensus price target as assigned by Wall Street analysts is $8, which translates to bulls needing to increase their stock price by 84.5% from its current value. Analyst projections state that TELA is forecast to be at a low of $8 and a high of $8.
TELA Bio Inc (TELA) estimates and forecasts
The year-over-year growth rate is expected to be 23.51%, up from the previous year.
Consensus estimates provided by 5 financial analysts predict the company will bring in an average of 17.37M in revenue for the current quarter. 5 analysts expect TELA Bio Inc to make 21M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 16.6M and 16.09M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 4.59%. Forecasts for the next quarter put sales growth at 30.53%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 12.91%.
TELA Dividends
TELA Bio Inc’s next quarterly earnings report is expected to be released on 2025-Mar-19.
TELA Bio Inc (NASDAQ:TELA)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 8.42% of TELA Bio Inc shares, and 72.47% of them are in the hands of institutional investors. The stock currently has a share float of 79.13%. TELA Bio Inc stock is held by 59.0 institutions, with ESSEX WOODLANDS MANAGEMENT, INC. being the largest institutional investor. By 2024-06-30, it held 16.6674% of the shares, which is about 4.11 million shares worth $19.32 million.
ORBIMED ADVISORS LLC, with 9.9644% or 2.46 million shares worth $11.55 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 1.1 shares worth $1.37 million, making up 2.80% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 738.48 shares worth around $0.92 million, which represents about 1.87% of the total shares outstanding.
